
Am J Psychiatry 158:1252-1257, August 2001
© 2001 American Psychiatric Association
Higher Than Normal Plasma Interleukin-6 Concentrations in Cancer Patients With Depression: Preliminary Findings
Dominique L. Musselman, M.D.,
Andrew H. Miller, M.D.,
Maryfrances R. Porter, B.A.,
Amita Manatunga, Ph.D.,
Feng Gao, M.P.H.,
Suzanne Penna, B.A.,
Brad D. Pearce, Ph.D.,
Jacque Landry, B.S.,
Susan Glover, M.D.,
J. Stephen McDaniel, M.D., and
Charles B. Nemeroff, M.D., Ph.D.
OBJECTIVE: This study investigated whether cancer patients with and without major depression exhibit immune system abnormalities similar to those reported in medically healthy, depressed subjects without cancer. METHOD: The study subjects consisted of patients diagnosed with pancreatic, esophageal, or breast cancer. Other groups consisted of subjects with major depression (without cancer) and healthy comparison subjects. Subjects diagnoses were made with the Structured Clinical Interview for DSM-III-R. Severity of depression was measured with the Hamilton Depression Rating Scale. Plasma concentrations of interleukin-6 (IL-6) and postdexamethasone cortisol were measured. RESULTS: Cancer patients with depression had markedly higher plasma concentrations of IL-6 than healthy comparison subjects and cancer patients without depression. Although significant correlations were found between Hamilton depression scale scores and plasma concentrations of postdexamethasone cortisol, no significant correlations were found between plasma IL-6 and postdexamethasone cortisol concentrations. CONCLUSIONS: Higher than normal plasma IL-6 concentrations were associated with a diagnosis of major depression in cancer patients. IL-6 may contribute to sickness behavior that has overlapping symptoms with major depression.
This article has been cited by other articles:

|
 |

|
 |
 
D. S. Davydow, S. V. Desai, D. M. Needham, and O. J. Bienvenu
Psychiatric Morbidity in Survivors of the Acute Respiratory Distress Syndrome: A Systematic Review
Psychosom Med,
May 1, 2008;
70(4):
512 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
J. Clin. Oncol.,
February 20, 2008;
26(6):
971 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Bower
Behavioral Symptoms in Patients With Breast Cancer and Survivors
J. Clin. Oncol.,
February 10, 2008;
26(5):
768 - 777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Jacobson, B. Rosenfeld, H. Pessin, and W. Breitbart
Depression and IL-6 Blood Plasma Concentrations in Advanced Cancer Patients
Psychosomatics,
February 1, 2008;
49(1):
64 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Miller and C. L. Raison
Immune System Contributions to the Pathophysiology of Depression
Focus,
January 1, 2008;
6(1):
36 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Steel, D. A. Geller, T. C. Gamblin, M. C. Olek, and B. I. Carr
Depression, Immunity, and Survival in Patients With Hepatobiliary Carcinoma
J. Clin. Oncol.,
June 10, 2007;
25(17):
2397 - 2405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Collado-Hidalgo, J. E. Bower, P. A. Ganz, S. W. Cole, and M. R. Irwin
Inflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors.
Clin. Cancer Res.,
May 1, 2006;
12(9):
2759 - 2766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Geracioti Jr., L. L. Carpenter, M. J. Owens, D. G. Baker, N. N. Ekhator, P. S. Horn, J. R. Strawn, G. Sanacora, B. Kinkead, L. H. Price, et al.
Elevated Cerebrospinal Fluid Substance P Concentrations in Posttraumatic Stress Disorder and Major Depression
Am J Psychiatry,
April 1, 2006;
163(4):
637 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rich, P. F. Innominato, J. Boerner, M. C. Mormont, S. Iacobelli, B. Baron, C. Jasmin, and F. Levi
Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer
Clin. Cancer Res.,
March 1, 2005;
11(5):
1757 - 1764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Miller, D. J. Bowen, M. K. Campbell, M. A. Diefenbach, E. R. Gritz, P. B. Jacobsen, M. Stefanek, C. Y. Fang, D. Lazovich, K. A. Sherman, et al.
Current Research Promises and Challenges in Behavioral Oncology: Report from the American Society of Preventive Oncology Annual Meeting, 2002
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2004;
13(2):
171 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Williams, J. C. Barefoot, and N. Schneiderman
Psychosocial Risk Factors for Cardiovascular Disease: More Than One Culprit at Work
JAMA,
October 22, 2003;
290(16):
2190 - 2192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Trikha, R. Corringham, B. Klein, and J.-F. Rossi
Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer: A Review of the Rationale and Clinical Evidence
Clin. Cancer Res.,
October 15, 2003;
9(13):
4653 - 4665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Glaser, T. F. Robles, J. Sheridan, W. B. Malarkey, and J. K. Kiecolt-Glaser
Mild Depressive Symptoms Are Associated With Amplified and Prolonged Inflammatory Responses After Influenza Virus Vaccination in Older Adults
Arch Gen Psychiatry,
October 1, 2003;
60(10):
1009 - 1014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pasic, W. C. Levy, and M. D. Sullivan
Cytokines in Depression and Heart Failure
Psychosom Med,
March 1, 2003;
65(2):
181 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Interleukins in Cancer Patients with Depression
Journal Watch Psychiatry,
September 5, 2001;
2001(905):
4 - 4.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2001
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|